Pfizer

17 de set. de 2026, 22:51 UTC

Pfizer Inc. is gaining modestly in after-market trading, influenced by fluctuations and the performance of Bristol-Myers Squibb's Phase 3 study results.

16 de set. de 2026, 20:10 UTC

Pfizer Inc faces social media scrutiny over its drug pipeline needs, contributing to a decline despite exceeding revenue and earnings expectations.

15 de set. de 2026, 23:02 UTC

Pfizer Inc. shares are roughly flat in after-market trading amid broader market sentiment affected by a decline in the New York Empire State Manufacturing Index.

14 de set. de 2026, 23:01 UTC

Pfizer Inc shares are lower in after-market hours, with no specific news identified. Broader market declines are linked to rising crude oil prices.

11 de set. de 2026, 23:06 UTC

Pfizer Inc shares are slightly higher in after-market hours, with no specific news identified. The broader market reacted to August's Consumer Price Index data.

9 de set. de 2026, 20:07 UTC

Pfizer Inc. is gaining during Wednesday's session despite mixed market reactions to its trademark deal with Novartis India, which may impact earnings.

8 de set. de 2026, 20:08 UTC

Pfizer shares are lower as the company announces a webcast featuring CEO Albert Bourla at the Morgan Stanley Healthcare Conference scheduled for September 2026.

4 de set. de 2026, 23:05 UTC

Pfizer Inc shares are lower in after-market hours, reflecting a slight decline since Friday's close amid mixed economic signals affecting market sentiment.

3 de set. de 2026, 23:01 UTC

Pfizer Inc. shares are lower in after-market hours, following a weak trading session and amid broader market softness from recent economic data on jobless claims.

2 de set. de 2026, 23:06 UTC

Pfizer Inc. shares are lower in after-market hours, amid a weaker ADP payrolls report signaling potential labor market weakness affecting future Federal Reserve policy.

1 de set. de 2026, 20:09 UTC

Pfizer Inc shares reached a 22-month high of $28.86 today, driven by a significant upward trend in the Pharmaceuticals sub-sector amid overall market gains.

31 de ago. de 2026, 23:06 UTC

Pfizer Inc shares rose in after-hours trading, holding above the 20-day moving average and near the upper end of their one-month range.

28 de ago. de 2026, 23:01 UTC

Pfizer Inc. shares are lower in after-market trading, continuing a trend from the previous three sessions. No specific news was identified to explain the decline.

27 de ago. de 2026, 23:02 UTC

Pfizer and BioNTech received FDA approval for their XFG-adapted COVID-19 vaccine, COMIRNATY XFG, boosting shares in after-market trading.

26 de ago. de 2026, 23:06 UTC

Pfizer Inc shares are lower in after-market hours amid notable volatility. Broader market weakness and a stronger U.S. Dollar Index contributed to the decline.

25 de ago. de 2026, 23:06 UTC

Pfizer Inc. shares are lower in after-market trading, reflecting weaker sentiment amid broader market declines linked to falling crude oil prices.

24 de ago. de 2026, 19:36 UTC

Pfizer Inc. shares are lower today, continuing a decline since Friday's close. The stock remains above its 20-day moving average.

21 de ago. de 2026, 23:01 UTC

Pfizer Inc shares are lower in after-market trading, reflecting a downward trend amid broader market volatility related to inflation and government debt concerns.

20 de ago. de 2026, 19:41 UTC

Pfizer Inc's shares are lower today amid a broader downturn in the Pharmaceuticals sub-sector, marking a shift from recent gains.

19 de ago. de 2026, 23:51 UTC

Pfizer Inc shares are lower in after-market hours, reversing gains from three consecutive sessions. No specific news was identified to explain the price action.

18 de ago. de 2026, 19:16 UTC

Pfizer reported second-quarter adjusted EPS of $0.77, exceeding estimates, and raised its sales outlook for fiscal year 2026, with shares trading higher.

17 de ago. de 2026, 23:36 UTC

Pfizer Inc shares are lower in after-market hours following the announcement of Xtandi's new indication for prostate cancer treatment. The broader market also declined.

14 de ago. de 2026, 23:51 UTC

Pfizer Inc. shares are higher in after-market hours amid broader economic concerns following a reported decline in U.S. retail sales for July.

13 de ago. de 2026, 23:16 UTC

Pfizer Inc shares are lower in after-market hours following a decline from earlier gains. No specific news was identified to explain the movement.

12 de ago. de 2026, 23:02 UTC

Pfizer shares rose after Chairman Albert Bourla bought 38,000 shares at $26.34, totaling about $1 million, signaling confidence in the company's prospects.

11 de ago. de 2026, 19:26 UTC

Pfizer Inc. shares are lower amid a $44 million settlement over its Chantix drug, which allegedly contained a cancer-linked substance.

10 de ago. de 2026, 23:01 UTC

Pfizer Inc. shares are lower in after-market hours, continuing a decline since Monday's close amid rising Treasury yields and inflation concerns.

8 de ago. de 2026, 00:02 UTC

Pfizer Inc shares are lower in after-market hours with no specific news identified. Broader market concerns about interest rate hikes continue to influence sentiment.

7 de ago. de 2026, 23:01 UTC

Pfizer Inc shares are lower in after-market hours, reaching a session low earlier. No specific news was identified to explain the decline.

6 de ago. de 2026, 23:51 UTC

Pfizer Inc shares are lower in after-market hours. The decline follows increased crude oil prices and a strengthening U.S. dollar, contributing to market volatility.